Literature DB >> 8039827

The peptide binding specificity of HLA-B27 subtypes.

N Tanigaki1, D Fruci, E Vigneti, G Starace, P Rovero, M Londei, R H Butler, R Tosi.   

Abstract

Five HLA-B27 subtypes, B*2701, B*2703, B*2704, B*2705, and B*2706, were tested for direct binding with twenty-six synthetic nonapeptides carrying the primary anchor residue motifs (combination of amino residues at positions 2 and 9) relevant to B*2705. The peptide sequences were derived from human HSP89 alpha, P53 and MBP. The alpha chains were immunospecifically isolated from LH (B*2701), CH (B*2703), WE1 (B*2704), BTB (B*2705), and LIE (B*2706) cells and their peptide binding was measured by the HLA class I alpha chain refolding assay. The data obtained indicated that the B27 subtypes tested can bind a common set of peptides carrying several different anchor residue motifs. The motifs, R-K and R-R, reported for B*2705 and a new motif H-R were accepted by B*2703, B*2704, and B*2706, but not by B*2701. However, other motifs, including known B*2702 and/or B*2705 motifs, R-H, R-L, R-A, and R-F, and a new motif found here, R-G, were apparently accepted by all B27 subtypes tested. The observed cross-peptide binding in the B27 subgroup is compatible with the so-called arthritogenic peptide hypothesis in the pathogenesis of ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039827     DOI: 10.1007/bf00167079

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  26 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 3.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

Review 4.  HLA-B27 and HLA-A2 subtypes: structure, evolution and function.

Authors:  J A López de Castro
Journal:  Immunol Today       Date:  1989-07

5.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

6.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.

Authors:  D Fruci; P Rovero; R H Butler; R Sorrentino; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain.

Authors:  S Y Choo; L A Fan; J A Hansen
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

9.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

10.  Genetic modulation of antigen presentation by HLA-B27 molecules.

Authors:  L Pazmany; S Rowland-Jones; S Huet; A Hill; J Sutton; R Murray; J Brooks; A McMichael
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  7 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.

Authors:  Nigil Haroon; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

3.  Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.

Authors:  D Fruci; R H Butler; G Greco; P Rovero; L Pazmany; E Vigneti; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 4.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 5.  HLA-B27: natural function and pathogenic role in spondyloarthritis.

Authors:  Andrew McMichael; Paul Bowness
Journal:  Arthritis Res       Date:  2002-05-09

6.  The peptide-binding motif for the human transporter associated with antigen processing.

Authors:  P M van Endert; D Riganelli; G Greco; K Fleischhauer; J Sidney; A Sette; J F Bach
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

7.  A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.

Authors:  Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.